作者: Vishal M. Balaramnavar , Rohit Srivastava , Neha Rahuja , Swati Gupta , Arun K. Rawat
DOI: 10.1016/J.EJMECH.2014.09.097
关键词:
摘要: Design and synthesis of protein tyrosine phosphatases-1B (PTP1B) inhibitors are important for the drugs targeted to treat diabetes obesity. The pharmacophore modeling, docking scaffold hopping techniques have been applied discover novel PTP1B inhibitors. ten prioritized compounds (115-119, 120-121, 127, 130-131) from library 86 were synthesized found positive in micro molar range in-vitro inhibitory assays as compared Suramin (IC50 9.5 μM). Among these five active (115-119) tested STZ-s induced diabetic rat model most compound 115 this test, was further C57BL/KsJ-db/db mice where it significantly improved OGTT along with fasting random blood glucose level. treatment by insulin resistance signaling restoring level normalizing serum lipid profile. Compound also augmented action modulating expression genes involved like IRS 1-2, PI3K, PTPN1, Akt2, AMPK PPAR-α. Western blot analysis both skeletal muscle liver demonstrated that proteins intermediate enzymes increased control group. investigated anti-adipogenic effect on 3T3L-1 cells. inhibited MDI accumulation a dose-dependent manner. oral bioavailability ∼10.29% after 30 mg/kg dosing assessed rat.